France AI in Oncology Market Insight
Published: 02 June 2026 | Report Format: Electronic (PDF)
France AI In Oncology Market will grow at a rate of 26.1% due to demand for precision medicine, rising cancer burden & staff shortages, accelerated drug discovery, enhanced diagnostic accuracy, government & research support.
France AI In Oncology Market Insights Forecasts to 2035
- The France AI In Oncology Market Size Was Estimated USD 182.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 26.1% from 2025 to 2035
- The France AI In Oncology Market Size is Expected to rise around USD 1.85 Billion by 2035
Notable Insights for the France AI In Oncology Market
- Segmentation on the basis of Component Type indicates that due to clinical decision support, diagnostics, and cloud-based deployment, the Software Solutions category will control approximately 64% of the French AI in Oncology Market in 2025.
- Segmentation on the basis of Cancer Type indicates that due to widespread screening programs and AI-enabled early lesion diagnosis, the Breast Cancer category has a nearly 23% share in the France AI in Oncology Market in 2025.
- Through the €14.9 million PreciseOnco project and €23.9 million total financing, the Innovative Health Initiative (IHI) supports the France AI in Oncology Market, promoting cross-border clinical innovation and AI-powered precision cancer treatment.
- Bpifrance's Artificial Intelligence and Cancer project, of 19 million euros, aims to consolidate the France AI in Oncology Market by reinforcing public-private R&D cooperation, strengthening oncology innovation, and enhancing the growth of AI in precision oncology.
Download the eBook (ToC)
Why Buy This Report
- This report offers an in-depth analysis on market size, growth projections, competitive landscape, and untapped opportunities within AI in diagnostics, digital pathology, precision oncology, and clinical decision support markets in France.
- It covers detailed information on each market segment, trends in technology adoption, regulatory evolution, investments and strategic efforts impacting future of AI in cancer care and patient treatment.
- This study helps stake holders make informed investment, expansion, partnership, and product development decisions by identifying the fastest growing markets, understanding market risk factors and competition benchmarks up to 2035.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France AI In Oncology Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France AI In Oncology Market
- Mistral AI
- Hugging Face
- The Good AI
- Artefact
- Capgemini
- Devoteam
- DiliTrust
- Kili Technology
- Sopra Steria
- Quantmetry
Recent Developments:
- In February 2026, Philips coordinated the PreciseOnco consortium, securing a €14.9 million IHI grant and €23.9 million total program budget to advance AI-powered precision cancer treatment across Europe.
- In July 2025, Owkin partnered with France Tissue Bank and NeoGenomics to develop the first AI-driven IHC foundation model, leveraging large-scale pathology datasets for oncology diagnostics.
Market Segmentation:
France AI In Oncology Market, By Component
- Software Solutions
- Hardware
- Services
France AI In Oncology Market, By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Other Cancer Types
France AI In Oncology Market, By Application
- Cancer Detection and Diagnosis
- Treatment Planning and Optimization
- Drug Discovery
- Drug Development and Clinical Trials
Expert Views:
France's AI in Oncology market is expected to witness significant growth through 2035 owing to increasing cancer prevalence, widespread adoption of precision medicine and strategic government support for innovation. AI-enabled diagnostics, digital pathology and drug discovery are gaining traction by enhancing clinical outcomes and operational efficiency. Backed by strategic investments, research collaborations and a well-established healthcare ecosystem, France is poised to continue as the premier hub in Europe for AI in oncology innovation.
Author: Komal and Radhika By Spherical Insights and Consulting